Germany Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Germany Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The German pharmaceuticals market had total revenues of $83.2 billion in 2022, representing a compound annual growth rate (CAGR) of 6.5% between 2017 and 2022.
- 0
- According to in-house research, in 2022, Germany accounted for 23.5% of the European pharmaceuticals market. The growth in the pharmaceutical market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in Germany stood at 13.9% of total health spending in 2021.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Germany pharmaceuticals market by value in 2022?
- What will be the size of the Germany pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Germany pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Germany’s pharmaceuticals market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent strategic partnerships?
8 COMPANY PROFILES
8.1. Novartis AG
8.2. F. Hoffmann-La Roche Ltd
8.3. Bayer AG
8.4. Boehringer Ingelheim GmbH
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent strategic partnerships?
8 COMPANY PROFILES
8.1. Novartis AG
8.2. F. Hoffmann-La Roche Ltd
8.3. Bayer AG
8.4. Boehringer Ingelheim GmbH
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Germany pharmaceuticals market value: $ billion, 2017-22
Table 2: Germany pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Germany pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Novartis AG: key facts
Table 5: Novartis AG: Annual Financial Ratios
Table 6: Novartis AG: Key Employees
Table 7: Novartis AG: Key Employees Continued
Table 8: F. Hoffmann-La Roche Ltd: key facts
Table 9: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 10: F. Hoffmann-La Roche Ltd: Key Employees
Table 11: Bayer AG: key facts
Table 12: Bayer AG: Annual Financial Ratios
Table 13: Bayer AG: Key Employees
Table 14: Bayer AG: Key Employees Continued
Table 15: Boehringer Ingelheim GmbH: key facts
Table 16: Boehringer Ingelheim GmbH: Key Employees
Table 17: Germany size of population (million), 2018-22
Table 18: Germany gdp (constant 2005 prices, $ billion), 2018-22
Table 19: Germany gdp (current prices, $ billion), 2018-22
Table 20: Germany inflation, 2018-22
Table 21: Germany consumer price index (absolute), 2018-22
Table 22: Germany exchange rate, 2018-22
Table 1: Germany pharmaceuticals market value: $ billion, 2017-22
Table 2: Germany pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Germany pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Novartis AG: key facts
Table 5: Novartis AG: Annual Financial Ratios
Table 6: Novartis AG: Key Employees
Table 7: Novartis AG: Key Employees Continued
Table 8: F. Hoffmann-La Roche Ltd: key facts
Table 9: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 10: F. Hoffmann-La Roche Ltd: Key Employees
Table 11: Bayer AG: key facts
Table 12: Bayer AG: Annual Financial Ratios
Table 13: Bayer AG: Key Employees
Table 14: Bayer AG: Key Employees Continued
Table 15: Boehringer Ingelheim GmbH: key facts
Table 16: Boehringer Ingelheim GmbH: Key Employees
Table 17: Germany size of population (million), 2018-22
Table 18: Germany gdp (constant 2005 prices, $ billion), 2018-22
Table 19: Germany gdp (current prices, $ billion), 2018-22
Table 20: Germany inflation, 2018-22
Table 21: Germany consumer price index (absolute), 2018-22
Table 22: Germany exchange rate, 2018-22
LIST OF FIGURES
Figure 1: Germany pharmaceuticals market value: $ billion, 2017-22
Figure 2: Germany pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Germany pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Germany, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Germany, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Germany, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2022
Figure 1: Germany pharmaceuticals market value: $ billion, 2017-22
Figure 2: Germany pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Germany pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Germany, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Germany, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Germany, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2022
